Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

The new assay can help develop products for hair re-growth.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Ascorbyl Tetraisopalmitate penetrates skin better in the stratum corneum than in the infundibulum.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

UT-018 speeds up wound healing and boosts hair growth in mice.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

Activin A promotes ear hair cell development, while follistatin delays it.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Targeting the AhR pathway may help treat alopecia areata.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

Tofacitinib may help treat severe hair loss, but more research is needed.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Baricitinib was effective in treating both early and late onset alopecia areata.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.